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26% of patients, respectively, require additional PTCA or bypass surgery
(CABG) within one year of PTCA. To determine whether these trials, which
include only a minority of all eligible patienta, reflect usual clinical practice,
we compared the rates with follow-up data obtainad in 1995 on a cohort of
151 consecutive women and 151 out of 587 randomly selected men who
underwent PTCA at a single centre between 1987-94 prior to introduction
of coronaty stents. Mean age (SD) of the patients was 56.2 (10.3) years.
Indications for PTCA were n (%): new onset angina in 52 (17), chronic stable
angina in 63 (27), unstable angina in 72 (24) and angina within 12 months
of Ml in 87 (29) patients. Multivessel coronary disease was present in 100
(33%) patients, and 110 (36%) had impaired LV function. The majority (91%)
had single veasel PTCA with angiographic success in 80Y0.After a median
(IQ Range) follow-up of 4.1 (2.2-6.1) years, event-free suwival from death,
Ml, CABG or repeat PTCA was identical in both sexes at 56%. First year
event rates, weighted for men, were:
CurrentStudy MeIa-Analyais Benastent
n= 302 n = 1710 (PTCA Arm) n = 257
ainale veasel multivssael
Mortality(all-cause)‘A 2.0 1.9 3.1 0.8
Additional 18.2 30.5 34.5 26,1
PTCNCABG“A (95”/0Cl 14.2,22.2)
PTCA trials appear to exaggerate the need for additional revasculariza-
tion, possibly becauae follow-up angiography is performed irrespective of
clinical indication; pre-PTCA patient counseling should be based on clinical
reetenosis ratea of the individual center concerned.
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1792-5/ Three-YearPatenCyandLateReCU~~e~CeO~e~han
6 YearsAfterCoronaryAngioplssty
H. Kitexume, 1.Kubo, T. Iwama, A. Suzuki. EfokutoHospital, Tokyo,Japan
To examine the long-term effects of corona~ angioplasty, lesions that were
patent at 3-8 months after angioplasty were followed-up angiographically
every 3 yeare. There were 802 lesions (pre-procedural stenosis, 85 + 11%;
residual atenosis, 21 + 12%; lesion length, 8 + 5 mm; stenosis at follow-up,
25 + 14Yo)successfully dilated between 1983 and 1986 that were patent
(5 50%) Onfollow-up angiogrephy at 3-6 months and were followed further
at our outpatient depanment. Repeat angiography was done for 480 lesions
at 3-5 years after follow-up angiography, for 328 lesions at S-6 yeare, and
for 105 Ieaions at 9 yeare. The number of lesions that were patent (&50%
stenosis), mildly stenosed (55-700/0stenosis) and severely stenosad (75-
lflO%Ostenosia) is shown in the Table. The 83 lesions that remained patent
throughout had the following levels of stenosis, pre-procedural, 83 & 12%;
residual, 20 * 12%; follow-up, 22 * 15Y.; 3+ years, 18 * 13YO;6-B years,
17+ 12%; and 9 years, 17* 12%. Most lesions remained patent for3 years,
but a significant number developed restenosis between 6 and 9 yeare.
Stenosis follow-up 3 year 6 yaar 9 yaar
Patent (G50%) 802 456 306 83
Mildatenosia(55-70%) 10 5 5
Reatenosis(75-100%) 14 (2.9%) 17 (5.2%) 17 (16.20A)
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~792-6]Long-ter~o”t~o~e~o,,o ,ng oroneV
Angiopiasty:CiinicaiandAngiographicResuitsofa
15-yearFoiiow-up
J. vom Dahl, J. Wagner, H.G. Klues, B.J. Measmer, P.Hanrath. Urriversity
Hoapital, Aachen, Germany
Between October 1978 and March 1983,290 consecutive patients (pts, 256
male, 60+ 6 years) undetwent elective PTCAwith 98Y0single-vessel PTCA.
Uaing non-ateerebie balloon catheters in gs~o, PTCA was successful in
207/290 pts (71%,.group A) and wae unsuccessful in 83 pts (gr. B) with 3 in-
hospitai deathe. Angiogrephy at6 monthe in 190/207 pts revealed restenosis
in 350A.
Follow-up by outpatient clinic visit or telephone intetview was available in
97% of pte (A: 199/207 pts; B: 78/80 pts) at 15*2 (12-17) years. Overall
aurvival waa63Y0(A: 64%; B: 81Yo)with cardiac deatha in 8Y0(A: 7%; B: 15%,
p < 0.05). Survival in gr. B was highest (89%) in 29 pts with early elective
CABG after unsuccessful (75% failure to cross the lesion due to technical
reasons) but uncomplicated PTCA compared to 54 pts without early CABG
(78% survival), and to 17 pta without any intervention despite failed PTCA
(65% suivival, p < 0.05). 71% of deaths in gr. A occurred ?5 years after the
first PTCA, whereas 83% of deaths in gr. B without reintervention occurred
within 5 years.
The incidence of non-fatal myocardial infarction (Ml) was 19% (A: 17%;
B: 25%) with 80% of Ml occurring >5 years after PTCA in non-PTCA veesel
territories. Coronaty interventions for restenosis or progressive CAO were
necessary in 46% of pts (A: 43%; B: 55%). At follow-up, 76% of pte had no
or mild angina pecforis (76% in A and B).
An excellent outcome was obsetved in 111pte with successful PTCAand
no need for reintewention (87% survival, 9% Ml, 64% with no or mild angina).
ln36/111 ptswithauccessful PTCAand noeariyreetenosis, angiogrephyafter
9 + 3 years revealed similar stenoses at the PTCA site (26 & 12% vs. 31
+ 14% at 6 months) with late restenosis in only 6%. 57% of all pts with late
angiography had new stenoses in other coronary arteries. Particularly pte
with angina had more frequently new stenoses and non-PTCA vessel related
Ml (55%).
Thus, successful PTCA in single-vessel disease results in excellent clin-
ical and angiographic long-term results. Adverse events are predominantly
related to the overall progression of CAD.
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1793-1] EfiectsofDobu@~ine~tresson~Yo~a diai~y~~oii~
ThickeninginthePresenoeof Partisior Compiete
Abaenceof FiowReaerve:implicationsfor
DobutemineStresaEchocardiography
D.A. Calnon, D.K. Glover, M. Ruiz, G. Vanzetto, D.D. Watson, G.A. Beller.
Univeraityof Virginia, Charlottesville, VA, USA
The diagnostic significance of relative (versus abeolute) hypokinesis during
dobutamine (Deb) etress is debated, To better define the effects of flow-
Iimitfng stenoses on absolute systolic wall thickening (SWT), Dob (2.5-30
@kg/rein) was infused in 15 dogs with etenoses which partially (Grp 1: n
= 8) or completely (Grp 2: n = 7) abolished flow resewe. Dob increaaed
normal zone flow (Grp 1: 0.0 + 0.1 to 2.7 + 0.2, Grp 2: 0.9 + 0.1 to 2.4
+ 0.3 ml/min/g; P < 0,001), while stenotic zone flow reserve was impaired
(Grp 1: 0.9+ 0.1 to 1.4+ 0.1 ml/min/g) or absent (Grp 2: 0.9+ 0.1 to 1.0.
+ 0.1 m!fmirVg).Dob increased SWT in the normal zone (Grp 1: 3.3 + 0.2
to 4.2 + 0.4 mm; Grp 2: 2.9 + 0.3 to 4.8 + 0.3 mm; P < 0.05). In Grp 1, a
biphasic reaponse to Dob was observed in the stenotic zone, with SWT of
2.7 + 0.3 mm, 3.6+ 0.2 mm, and 2.9 + 0.4 mm (at baseline, 10 pg/kg/min,
and 30 @@rein, respectively). In Grp 2, a flat response to Dob was eeen
in the stenotic zone (3.4 + 0,5 mm, 3,8 + 0.4 mm, and 2.7 + 0.4 mm,
respectively; P= NS). in both groups, persistent regional systolic dysfunction
was obsemd 45 min after Dob (Grp 1: 1.7 + 0.4 mm; Grp 2: 1.6 + 0.4 mm; P
< 0.05) consistent with myocardial stunning. Thus, in these canine models,
Dob induced a biphasic responae when flow resewe was partially impaired,
a flat responae when flow reserve was absent, and absolute hypokinesis
oriydurtng recovery.To optimize sensitivity of Dob stress echocardiography,
failure to develop hyperkinesis (relative hypokineais) should be interpreted
as abnormal, and imaging should be performed during recovery.
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[793-2]MYocardiaiLac~teproductioninpatientswith
CoronaryArteryDieeaesUndergoingStress
Echocardiography.A ProspectiveComparative
StudyBetweenArbutamineandDobutamine
F.P.Job, S. Axer, R. Frieske, O.A, Breithardt, M. Carletti, D.C. Fischer,
P.Hanrath. Medical Clinic/, University Hospital RkVTHAachen, Germany
To study the metabolic effect of dobutamine (D) and arbutamine (A) during
stress echocardiography n = 22 consecutive patients (pts) were randomly
assignad to either D (n = 12, mean age 59 + 10.1) or A (n = 10, mean age
61.2 + 9.4). Stress echocardiography was performed immediately before
coronary angiography. Blood samples for lactate Ieveis were drawn from
the coronary sinus (CSlact), the descending aorta (Alact) and the femoral
vein (Vlact) at base, peak stress and 2, 5, 10, 15 min after peak streaa.
The mean peak pressure rate product did not differ significantly between
both groups (19451 + 4017 vs 18725 + 3411). Significant coronary artery
diaeaae (diameter stenosis >50% in two planes) was proven in all pts. When
mean lactate levels (mmol/1) at baee and peak were compared, significant
differences were obtained for A at all sites: Vlacf (0.76 + 0.11 vs 1.36 +
0.48; p < 0.05) CSlact (0.51 + 0.14 vs 1.36 + 0.43; p c 0.01) and Alacf
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(0.51 + 0.08 vs 1.12 + 0.31; p < 0.01) butnot for D: Vlacf (0.82 +’0.32 vs
0.75 + 0.46; p = 0.334), CSlact (0.44• 0.24 vs 1.12 + 0.41; p = 0.083) and
Alaot (0.54+ 0.34 vs 0.73 * 0.41; p = 0.083). When the difference between
Alaof and CSlact was calculated, all pts showed lactate extraction under rest
conditions and turned to lactate production during A and D infusion. Lactate
pmduefion was present at least 15 min after termination of both, A and D
infusion without a significant difference within the groups. The sensitivity of
A and D stress echo for detecting CAD was 82% versus 84%, respectively
(not significant).
Cone/usiomBothdrugswere highly sensitive indetaofing newlydeveloped
wall motion abnormalities diagnostic for CAD. In all pts with CAD, D and A
cause lactate production for at least15 min after the end of the administration.
In contrast to D, A also causes a significant elevation of peripheral venous
lactate Ievelsdueto ischemia inexfracardial tissue. Becauseof the increasing
use of A in stress echocerdiography theclinicel importance of this newfinding
remains to be determined.
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n7933 Assessment of Collateral Blood Flow Distribution
During Myocardlal Ischemia With Streaa Myocardlal
Contrast Echocardiography in Humsns
Y. Sakata, K. Kodama, Y.-J. Lim i, F. lshikura, A. Hirayama. Osaka Police
,40spifa/,Osaka, Japan, 1Kawachi Gerrerzr/Hospital, F/igasfri-Osaka,Japan
Unlike intheanimal experiments, howthe collateral perfusion supply changes
during myoeerdial stress and protects against ischemia has not been evalu-
ated in humans. To assess the dynamic mllateral function against increased
myocardial oxygen demand, myocardial Contrasteohocardiographyand rapid
atrial pacing were conduofed in 20 patients with angiographically significant
coronary collaterals to the occluded left anterior descending coronary artery
from the right coronary artety. Sonicsted contrast material was injected to
the right coronaIy artery before and during pacing to determine the peak
background-subtracted contrast intensity (PCI) in the occluded bed as a pa-
rameter of collateral blood flow. Regional wall motion (RWM) was assessed
bytwodimensional echooardiogrephy,graded on a5-point scale (O= normal
to 4 = dyskinetic). PCI before pacing ranged from 0.15 to 61.6 U, mean 14.1
U, and was significantly correlated with RWM before pa~ng (p < 0.05) but
not with RWM during pacing. PCI was significantly decreaaad during pacing
(P= 0.01, ran9e 0.0 to 33.0 U, mean 7.9 U) and was significantly correlated
with RWM during pacing (p < 0.01). Deterioration of RWM was not corre-
lated with the PCI before or during pacing, but was closely related with the
O/.decrease in PCI during pacing (p < 0.05). These findings suggestad that
1) RWM was associated with collateral blood flow before or during stress,
and 2) a significant decrease in collateral blood flow was associated with
provocation of myocardial ischemia. In conclusion, strese MCE enabled us
simultaneous asaeesment of dynamic changes in collateral perfusion and
regional function in patiente with coronaty artery disease.
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n7934 The Flow-Function Relationship in Patients withChronic Coronary Artery Disease and Reduced
Resting Function: a Positron Emission Tomography
and 2d-Echocardiography Study with Coronary
Vasodilator Strass
G. Parodi, M.A. Torres, R. Sicari, A. Giorgetti, O. Parodi, E. Picano. CfVr?
hrstitute of Clinical Physiology Pisa, Italy
in order to elucidate the flow correlates underlying the speclrum of me-
chanical reeponses of segments with resting dysfunction during vasodilator
atrese, 17 patients with coronary artery disease and left ventricular dysfunc-
tion undetwent evaluation of regional function (2D-eohocsrdiogrephy) and
myocardial blood flow by positron emiesion tomography (PET) and N13-
ammonia both at rest and following dipyridamole (DIP, 0.56 mg/kg over 4’).
Forty segmenta with resting dysfunction oould be evaluated. Each segment
wee soorad from 1 = norrnal/hyperkinetic to 4 = dyskinetic. Four patterns of
eohooerdiographic response were identified: “normal” (regional wall motion
soore, RWMS: rest = 1, DIP= 1), n = 45; “ischemic” (RWMS: rest >1, DIP
> rest), n = 9; “responders” (resting eoore >1, improvement 21 grade), n
. 11; “non-responders” (resting score >1, no change), n = 20. In “normal”
segments there was an increase in flow (rest= 0.8& 0.2 vs DIP = 1.9+ 0.9
mUmin/g, p = 0.01) with a hyperkinetic Contradion Pattern. “Responders”
showed an upeloping flow-function respcmse”during stress, i.e. increased
function (RWMS: rest= 2.5 * 0.5 vs DIP = 1.2 + 0.4) and flow (rest= 0.7
& 0.3 vs DIP = 1.9 * 1.4 mumitig, p = 0.01); “non-responders” had a flat
flow-function reeponee, i.e. fixed funofion (RWMS: reat and DIP= 2.6+ 0.5)
and no flow increase (reat = 0.6 + 0.2 vs DIP = 0.9 + 0.5 ml-/min/g, p =
ns); “ischemic” segments exhibitad a downsloping flow-function reaponse,
i.e. worsened funotion (RWMS: reet = 2 A 0.5 vs DIP = 3.1 + 0.6) and no sig-
nifioent flow change (rest= 0.7+ 0.3 vs DIP =0.8 + 0.2 mUmirt/g, p = ns). In
conclusion, myocardial segments with a resting dysfunction and a contractile
resetve more often exhibit a residual flow reserve, whereae segments with
a fixed or woes.aningmechanical pattern show a flat flow reeponse during
corona~ vasodilator stress.
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m7935 Progression of Mitral Regurgitation and Left
Ventricular Remodeling: A Quantitative Doppler
Echocardiographic Study
M.E. Sarano, A. Rossi, K.W. Klarich, J.B. Seward. Mayo Clink Rochester
Minnesota, USA
Mitral regurgitation (MR) due to intrinsic valvular disease causea left ventric-
ular (LV) enlargement but the progression of the degree of regurgitation and
the progression of the degree of MR and of LV remodeling occurring with time
is yet unknown. In 21 patients (65 + 7 years, 17 males) Doppler echocardio-
graphic quantitation of MR and LV volumes and function wae repeated 1.1
+ 1.3 years apart. At time of repeat evaluation no change in blood preasure
(132 +16 vs 135+11 mrnfHg, P = 0.38) and heatt rate (68+9 vs 72 + 11
bpm, P = 0.19) were noted-Changes were:
Variables First Evaluation Second Evaluation P
Regurgitantvolume (ml) 81 k 47 97 s 48 0,005
Regurgitantfraction(O/.) 48& 15 55+ 14 OJXX3
Effectiveregurgitantorifice 54* 34 87& 44 0.016
End diastolicvolume(ml/mz) 124 *33 134 *37 0.01
End syatolicvolume(ml/m2) 43* 15 48* 21 0.14
Electionfraction(“/0) 66+ 7 65& 8 0.72
Endsystolicwall stress (g/cm2) 170 i 35 169 +33 0.s4
The change in volume overload was highly variable (regurgitant volume
changes from –13 ml to +97 ml) and ahowed no correlation to changes in
left ventricular function (P > 0.10)
/n corrc/usion: In chronic mitral regurgitation over a one year period: 1)
marked changes in regurgitant volume but also effective regurgitant orifice
are observed with 2) a mild increase in left ventricular eize but no measurable
change in function 3) observation of wide individual variability suggesting
that regular quantitation of regurgitation is clinically relevant to assess the
progression of volume overload and left ventricular remodeling in mitral
regurgitation.
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1793-61Near Norma,i~tionofLV MaasFo,,owin9 Toronto
Stentless Porcine Valve Aortic Valve Replacement
H. Rakowski, C.D. Gresser, S.C. Siu, B.L. Strangemore, T.E. David. Toronto
Hospita/, Toronto, Canada
Aortic valve replacement (AVR) with atented tissue and metal prostheses
results in persietingly abnormal aortic valve areas (AVA) and incomplete
regression of LV hypertrophy (LVH). The Toronto Stantless Porcine valve
(SPV) allows insertion of larger valve sizes and greater potential for LVH
regression. The clinical and echo outcomes of 167 consecutive pts (age 62
+ 11yrs, 115 men) undergoing SPV AVR were prospectively etudied ae patt
of an FDA protocol. Pre-operative NYHA class was 2-4 in 48Y0.LV maas
index (LVMI,g/m2) and AVA (cmz)were assessed prior to discharge (B), and
at 3-6, 12, 24 months (m) postop. Results:
B 3-6m 12 m 24 m
!% 167 154 137 95
LVMI 121 l 40 111* 35* 104 * 30” 98 +26*
AVA 2.0+0.5 2.0 + 0.5 2.2 + 0.6*2.210.6*
*p <0.002 comparedto B
Freedom from reoperation orcardiac death was 99% at 24 m; all survivors
were in NYHA claes 1-2. SPV design allowed insertion of larger valve aizes
(27 or 29) in 65% of pts. LVMI decreased at follow-up as early as 3-8 m
postoperatively.AVAincreased further by 12mandwas larger than previously
reported for stented or metal valvee; AVA varied with valve size (2%’25,1.8
+ 0.5; 27, 2.2 + 0,4, 29; 2.5 * 0.7). Theee changee in LVMI and AVA were
also evident when the study group was stratified by gender and SPV size.
At 24 m near normalization of LVMI occurred for each SPV size and gender.
Cone/usions:The SPVvalve permitted the use of Iargevalvesizee, with large
effeetive AVA, and persistent near normalization of LVMI.
